Loading…

9 MECHANISMS OF ENDOTHELIAL BARRIER ENHANCEMENT INDUCED BY ADENOSINE TRIPHOSPHATE

Purpose of StudyEndothelial barrier dysfunction is often the underlying cause of vascular leakage and edema. It is important therefore to find ways to preserve barrier properties. Extracellular adenosine triphosphate (ATP) has been known to protect endothelial barrier. In this study we defined the m...

Full description

Saved in:
Bibliographic Details
Published in:Journal of investigative medicine 2005-03, Vol.53 (2), p.S358-S358
Main Author: Kolosova, I.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page S358
container_issue 2
container_start_page S358
container_title Journal of investigative medicine
container_volume 53
creator Kolosova, I.
description Purpose of StudyEndothelial barrier dysfunction is often the underlying cause of vascular leakage and edema. It is important therefore to find ways to preserve barrier properties. Extracellular adenosine triphosphate (ATP) has been known to protect endothelial barrier. In this study we defined the mechanisms of endothelial barrier enhancement caused by extracellular ATP.MethodsCombination of pharmacological and molecular approaches is used in this study.Summary of ResultsATP and its non-hydrolyzed analogues enhanced barrier properties of cultured endothelial cell monolayers, caused remodeling of cell-cell junctions, and significantly attenuated thrombin-induced barrier disruption. Intracellular Ca2+ increase and Erk activation caused by ATP were irrelevant to barrier enhancement. Inhibitory analysis and silencing RNA revealed the involvement of G proteins (specifically Gαq and Gαi2) as well as protein kinase A and its substrate VASP in ATP-induced barrier enhancement. Contractile state of endothelial cells governed by myosin light chain (MLC) phosphorylation underlies barrier properties. ATP treatment decreased MLC phosphorylation and specifically activated myosin-associated phosphatase. Depletion of Gαq with siRNA prevented ATP-induced activation of myosin phosphatase.ConclusionsWe conclude that ATP-induced barrier-improving mechanism is independent from intracellular Ca2+, but involves activation of myosin phosphatase via novel G protein coupled mechanism and PKA.
doi_str_mv 10.2310/6650.2005.00206.8
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1786923817</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4045565001</sourcerecordid><originalsourceid>FETCH-LOGICAL-b1077-473ae5aab145c0d4b4382112b06788bcf54b183347e93eb85e2a838fd77733613</originalsourceid><addsrcrecordid>eNqNkM1Og0AURidGE2v1AdxN4lZwfpiZy5LCVEgoVKALVxOmhcTG2gp24ds7tT6Aq_vl5nz3Jgehe0p8xil5klK4RIjwCWFE-nCBJlQR8IBJdekyAeoJAeE1uhnHrYOkCNkEvYR4oeM0KrJ6UeNyjnWRlE2q8yzK8SyqqkxXbueAWC900eCsSFaxTvDsFUeJLso6KzRuqmyZlvUyjRp9i6769n3s7v7mFK3muolTLy-fszjKPUuJUl6geNuJtrU0EGuyCWzAgVHKLJEKwK57EVgKnAeqC3lnQXSsBQ79RinFuaR8ih7Odw_D_vPYjV9muz8OH-6loQpkyDhQ5Sh6ptbDfhyHrjeH4W3XDt-GEnMyZ07mzMmc-TVnwHUezx272_4D_wFRomPt</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1786923817</pqid></control><display><type>article</type><title>9 MECHANISMS OF ENDOTHELIAL BARRIER ENHANCEMENT INDUCED BY ADENOSINE TRIPHOSPHATE</title><source>Criminology Collection</source><source>Social Science Premium Collection (Proquest) (PQ_SDU_P3)</source><source>SAGE:Jisc Collections:SAGE Journals Read and Publish 2023-2024:2025 extension (reading list)</source><creator>Kolosova, I.</creator><creatorcontrib>Kolosova, I.</creatorcontrib><description>Purpose of StudyEndothelial barrier dysfunction is often the underlying cause of vascular leakage and edema. It is important therefore to find ways to preserve barrier properties. Extracellular adenosine triphosphate (ATP) has been known to protect endothelial barrier. In this study we defined the mechanisms of endothelial barrier enhancement caused by extracellular ATP.MethodsCombination of pharmacological and molecular approaches is used in this study.Summary of ResultsATP and its non-hydrolyzed analogues enhanced barrier properties of cultured endothelial cell monolayers, caused remodeling of cell-cell junctions, and significantly attenuated thrombin-induced barrier disruption. Intracellular Ca2+ increase and Erk activation caused by ATP were irrelevant to barrier enhancement. Inhibitory analysis and silencing RNA revealed the involvement of G proteins (specifically Gαq and Gαi2) as well as protein kinase A and its substrate VASP in ATP-induced barrier enhancement. Contractile state of endothelial cells governed by myosin light chain (MLC) phosphorylation underlies barrier properties. ATP treatment decreased MLC phosphorylation and specifically activated myosin-associated phosphatase. Depletion of Gαq with siRNA prevented ATP-induced activation of myosin phosphatase.ConclusionsWe conclude that ATP-induced barrier-improving mechanism is independent from intracellular Ca2+, but involves activation of myosin phosphatase via novel G protein coupled mechanism and PKA.</description><identifier>ISSN: 1081-5589</identifier><identifier>EISSN: 1708-8267</identifier><identifier>DOI: 10.2310/6650.2005.00206.8</identifier><language>eng</language><publisher>London: Sage Publications Ltd</publisher><ispartof>Journal of investigative medicine, 2005-03, Vol.53 (2), p.S358-S358</ispartof><rights>2015 American Federation for Medical Research, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><rights>Copyright: 2015 (c) 2015 American Federation for Medical Research, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/1786923817/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$H</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1786923817?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,776,780,21355,21373,27901,27902,33588,33746,43709,43790,74192,74281</link.rule.ids></links><search><creatorcontrib>Kolosova, I.</creatorcontrib><title>9 MECHANISMS OF ENDOTHELIAL BARRIER ENHANCEMENT INDUCED BY ADENOSINE TRIPHOSPHATE</title><title>Journal of investigative medicine</title><description>Purpose of StudyEndothelial barrier dysfunction is often the underlying cause of vascular leakage and edema. It is important therefore to find ways to preserve barrier properties. Extracellular adenosine triphosphate (ATP) has been known to protect endothelial barrier. In this study we defined the mechanisms of endothelial barrier enhancement caused by extracellular ATP.MethodsCombination of pharmacological and molecular approaches is used in this study.Summary of ResultsATP and its non-hydrolyzed analogues enhanced barrier properties of cultured endothelial cell monolayers, caused remodeling of cell-cell junctions, and significantly attenuated thrombin-induced barrier disruption. Intracellular Ca2+ increase and Erk activation caused by ATP were irrelevant to barrier enhancement. Inhibitory analysis and silencing RNA revealed the involvement of G proteins (specifically Gαq and Gαi2) as well as protein kinase A and its substrate VASP in ATP-induced barrier enhancement. Contractile state of endothelial cells governed by myosin light chain (MLC) phosphorylation underlies barrier properties. ATP treatment decreased MLC phosphorylation and specifically activated myosin-associated phosphatase. Depletion of Gαq with siRNA prevented ATP-induced activation of myosin phosphatase.ConclusionsWe conclude that ATP-induced barrier-improving mechanism is independent from intracellular Ca2+, but involves activation of myosin phosphatase via novel G protein coupled mechanism and PKA.</description><issn>1081-5589</issn><issn>1708-8267</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>ALSLI</sourceid><sourceid>BGRYB</sourceid><sourceid>M0O</sourceid><recordid>eNqNkM1Og0AURidGE2v1AdxN4lZwfpiZy5LCVEgoVKALVxOmhcTG2gp24ds7tT6Aq_vl5nz3Jgehe0p8xil5klK4RIjwCWFE-nCBJlQR8IBJdekyAeoJAeE1uhnHrYOkCNkEvYR4oeM0KrJ6UeNyjnWRlE2q8yzK8SyqqkxXbueAWC900eCsSFaxTvDsFUeJLso6KzRuqmyZlvUyjRp9i6769n3s7v7mFK3muolTLy-fszjKPUuJUl6geNuJtrU0EGuyCWzAgVHKLJEKwK57EVgKnAeqC3lnQXSsBQ79RinFuaR8ih7Odw_D_vPYjV9muz8OH-6loQpkyDhQ5Sh6ptbDfhyHrjeH4W3XDt-GEnMyZ07mzMmc-TVnwHUezx272_4D_wFRomPt</recordid><startdate>200503</startdate><enddate>200503</enddate><creator>Kolosova, I.</creator><general>Sage Publications Ltd</general><scope>AAYXX</scope><scope>CITATION</scope><scope>0-V</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AM</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ALSLI</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BGRYB</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K7.</scope><scope>K9.</scope><scope>M0O</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PRQQA</scope><scope>Q9U</scope></search><sort><creationdate>200503</creationdate><title>9 MECHANISMS OF ENDOTHELIAL BARRIER ENHANCEMENT INDUCED BY ADENOSINE TRIPHOSPHATE</title><author>Kolosova, I.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b1077-473ae5aab145c0d4b4382112b06788bcf54b183347e93eb85e2a838fd77733613</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kolosova, I.</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Social Sciences Premium Collection【Remote access available】</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Criminal Justice Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Social Science Premium Collection (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Criminology Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Criminal Justice (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Criminal Justice Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Research Library (ProQuest)</collection><collection>Research Library (Corporate)</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>ProQuest Health &amp; Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health &amp; Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Social Sciences</collection><collection>ProQuest Central Basic</collection><jtitle>Journal of investigative medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kolosova, I.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>9 MECHANISMS OF ENDOTHELIAL BARRIER ENHANCEMENT INDUCED BY ADENOSINE TRIPHOSPHATE</atitle><jtitle>Journal of investigative medicine</jtitle><date>2005-03</date><risdate>2005</risdate><volume>53</volume><issue>2</issue><spage>S358</spage><epage>S358</epage><pages>S358-S358</pages><issn>1081-5589</issn><eissn>1708-8267</eissn><abstract>Purpose of StudyEndothelial barrier dysfunction is often the underlying cause of vascular leakage and edema. It is important therefore to find ways to preserve barrier properties. Extracellular adenosine triphosphate (ATP) has been known to protect endothelial barrier. In this study we defined the mechanisms of endothelial barrier enhancement caused by extracellular ATP.MethodsCombination of pharmacological and molecular approaches is used in this study.Summary of ResultsATP and its non-hydrolyzed analogues enhanced barrier properties of cultured endothelial cell monolayers, caused remodeling of cell-cell junctions, and significantly attenuated thrombin-induced barrier disruption. Intracellular Ca2+ increase and Erk activation caused by ATP were irrelevant to barrier enhancement. Inhibitory analysis and silencing RNA revealed the involvement of G proteins (specifically Gαq and Gαi2) as well as protein kinase A and its substrate VASP in ATP-induced barrier enhancement. Contractile state of endothelial cells governed by myosin light chain (MLC) phosphorylation underlies barrier properties. ATP treatment decreased MLC phosphorylation and specifically activated myosin-associated phosphatase. Depletion of Gαq with siRNA prevented ATP-induced activation of myosin phosphatase.ConclusionsWe conclude that ATP-induced barrier-improving mechanism is independent from intracellular Ca2+, but involves activation of myosin phosphatase via novel G protein coupled mechanism and PKA.</abstract><cop>London</cop><pub>Sage Publications Ltd</pub><doi>10.2310/6650.2005.00206.8</doi></addata></record>
fulltext fulltext
identifier ISSN: 1081-5589
ispartof Journal of investigative medicine, 2005-03, Vol.53 (2), p.S358-S358
issn 1081-5589
1708-8267
language eng
recordid cdi_proquest_journals_1786923817
source Criminology Collection; Social Science Premium Collection (Proquest) (PQ_SDU_P3); SAGE:Jisc Collections:SAGE Journals Read and Publish 2023-2024:2025 extension (reading list)
title 9 MECHANISMS OF ENDOTHELIAL BARRIER ENHANCEMENT INDUCED BY ADENOSINE TRIPHOSPHATE
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-23T22%3A56%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=9%20MECHANISMS%20OF%20ENDOTHELIAL%20BARRIER%20ENHANCEMENT%20INDUCED%20BY%20ADENOSINE%20TRIPHOSPHATE&rft.jtitle=Journal%20of%20investigative%20medicine&rft.au=Kolosova,%20I.&rft.date=2005-03&rft.volume=53&rft.issue=2&rft.spage=S358&rft.epage=S358&rft.pages=S358-S358&rft.issn=1081-5589&rft.eissn=1708-8267&rft_id=info:doi/10.2310/6650.2005.00206.8&rft_dat=%3Cproquest_cross%3E4045565001%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-b1077-473ae5aab145c0d4b4382112b06788bcf54b183347e93eb85e2a838fd77733613%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1786923817&rft_id=info:pmid/&rfr_iscdi=true